No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Glycine Reuptake Inhibitors (GRIs) are a class of drugs used to treat mental disorders such as depression, anxiety, and schizophrenia. GRIs work by blocking the reuptake of glycine, an amino acid neurotransmitter, in the brain. This increases the amount of glycine available to the brain, which can help to reduce symptoms of mental disorders. GRIs are often used in combination with other medications, such as antidepressants, to provide a more comprehensive treatment plan.
GRIs are generally well-tolerated and have fewer side effects than other medications used to treat mental disorders. However, they can cause some side effects, such as drowsiness, dizziness, and nausea.
Some companies in the Glycine Reuptake Inhibitor market include Eli Lilly, Pfizer, and AstraZeneca. Show Less Read more
